Using mRNA differential display, we found that the gene for NAD ϩ -dependent glycerol phosphate dehydrogenase (GPDH; EC 1.1.1.8) is induced in rat brain following seizure activity. Northern blot and in situ hybridization analysis confirmed the differential display results; they also showed, in a separate model of neuronal activation, that after thermal noxious stimulation of the hindpaws, a similar increase in GPDH mRNA occurs in the areas of somatotopic projection in the lumbar spinal cord. Surprisingly, administration of analgesic doses of morphine or the nonsteroidal antiinflammatory drugs aspirin, metamizol (dipyrone), and indomethacin also increased GPDH mRNA levels in rat spinal cord. The opioid receptor antagonist naloxone completely blocked morphine induction of GPDH but had no effect on GPDH induction by noxious heat stimulation or metamizol treatment, implicating different mechanisms of GPDH induction. Nevertheless, in all cases, induction of the GPDH gene requires adrenal steroids and new protein synthesis, as the induction was blocked in adrenalectomized rats and by cycloheximide treatment, respectively. Our results suggest that the induction of the GPDH gene upon peripheral noxious stimulation is related to the endogenous response to pain as it is mimicked by exogenously applied analgesic drugs.
Altered gene expression with up-or down-regulation of specific proteins such as immediate early genes (Hunt et al., 1987; Morgan et al., 1987; Naranjo et al., 1991a Naranjo et al., , 1997 Yamagata et al., 1993; Link et al., 1995) , kinases Konietzko et al., 1999) , growth factors (Zafra et al., 1990) , and heat shock proteins (Wong et al., 1992) has been observed in a variety of experimental models of neuronal activity. Induction of seizure activity by the administration of pentylenetetrazole (PTZ) or kainic acid (KA) to rats has been established as a model to study the molecular events triggered by bursting activity. On the other hand, thermal noxious stimulation is a physiological model of plasticity where changes in the genetic program are thought to provide the molecular basis for adaptive/reparative changes. Thus, noxious stimulation leads to transactivation of target genes directly involved in spinal cord function, including immediate early genes, proenkephalin, prodynorphin, and substance P (Hunt et al., 1987; Iadarola et al., 1988; Noguchi et al., 1989; Sonnenberg et al., 1989; Naranjo et al., 1991) . Furthermore, administration of analgesic drugs counteracts these changes in gene expression. A reduction in the extent of c-Fos accumulation in the dorsal horn after pain has been reported following morphine (Presley et al., 1990; Tölle et al., 1994) and nonsteroidal antiinflammatory drug (NSAID) treatment (Abbadie and Besson, 1994; Taylor et al., 1998) . A correlation between analgesic effect and reduction in c-Fos immunoreactivity in the deep layers of the dorsal horn has been proposed (Presley et al., 1990) .
Glycerol phosphate dehydrogenase (GPDH) is a soluble, multifunctional NAD ϩ -linked enzyme associated with the metabolism of triglycerides. It catalyzes the reversible reduction of dihydroxyacetone phosphate to glycerol phosphate, the precursor for phospholipids and triglycerides that is used for the biosynthesis of membrane components (Lin, 1977) . The GPDH gene is expressed in most adult rat tissues and is regulated by a complex interaction of genetic, environmental, and hormonal factors (Wise and Green, 1979; Ratner et al., 1981) . In neural tissue, this interaction encompasses cellto-cell contact; that is, the expression of GPDH in Berg-mann glial cells depends on the interaction with adjacent Purkinje cells (Fisher and Mullen, 1988) and the action of several hormones including hydrocortisone, insulin, triiodothyronin, and catecholamines (McGinnis and Vellis, 1974; Breen et al., 1978; Forest et al., 1983; Grimaldi et al., 1983) . In particular, the regulation of GPDH expression by glucocorticoids has been well characterized in the rat central nervous system (de Vellis and Inglish, 1968; Masters et al., 1994) , in primary cultures of oligodendrocytes (Kumar et al., 1989) , and in C6 glioma cells Kumar et al., 1985) . Nevertheless, the level of GPDH expression and its pattern during development and mechanism of regulation are cell specific (Laatsch, 1962; de Vellis and Inglish, 1973) .
To identify genes whose expression is part of the genetic program triggered by neuronal activation in the hippocampus or in the spinal cord following seizure or noxious stimulation, respectively, we have employed a modification of the mRNA differential display technique (Liang and Pardee, 1992; Bauer et al., 1993) . Here we report the induction of the GPDH gene upon both forms of neuronal activation as well as following the administration of analgesic drugs. Importantly, in all cases, the induction of the GPDH gene depends on glucocorticoids and requires de novo protein synthesis.
MATERIALS AND METHODS

Animals
Adult male Sprague-Dawley rats (200 -300 g) were used in the differential display/PCR experiments, and Wistar rats (200 -300 g) were used in all other experiments. Cycloheximide (CHX) (in dimethyl sulfoxide; 120 mg/kg), PTZ (in phosphate-buffered saline; 50 mg/kg), KA (in phosphate-buffered saline; 8 mg/kg), indomethacin (in saline/25% ethanol; 1, 2.5, and 4.5 mg/kg), metamizol (in saline; 50, 125, and 250 mg/kg), and naloxone (in saline 1 mg/kg) were administered by intraperitoneal injection. Dexamethasone (DEX; in polyethylene glycol 200/2% ethanol; 0.4 mg/kg) and morphine (in saline; 1, 5, and 10 mg/kg) were injected subcutaneously. Animals that received CHX or naloxone were injected 30 min prior to drug treatments or thermal noxious stimulation. Animals that did not exhibit the typical pattern of motor seizures after PTZ injection were excluded from the experiments. Control animals were injected with a similar volume of saline. Noxious stimulation was applied by immersion of both hindpaws in water at 52°C for 30 s. Sham animals were handled in a similar way with the water bath kept at 37°C. Adrenalectomy was carried out bilaterally, and animals were maintained 6 -14 days, receiving 0.9% saline before use in the experiments. All animals were killed by guillotine decapitation at appropriate times.
RNA isolation and differential display
Extraction of brain and spinal cord total RNA was carried out as described (Iadarola et al., 1988) . Two independent RNA samples were isolated from hippocampus of animals 5 h after phosphate-buffered saline injection, 5 h after PTZ-induced seizure, and 4 h after PTZ-induced seizure in the presence of CHX. Differential display was carried out as described (Liang and Pardee, 1992; Bauer et al., 1993) with minor modifications. In brief, 200 g of total RNA of each sample was reversetranscribed with a two-base-anchored 13-mer primer T 11 GA. Subsequent PCR reactions were conducted with a single arbitrary forward and reverse 10-mer primer GATGGCCTGG using 2 l (1:10) of the RT reaction. Control reactions were performed with 20 g of total RNA and water instead of cDNA. Amplification was carried out in the presence of [␣- 33 P]dATP in a reaction volume of 20 l and the following cycling conditions: predenaturation at 94°C for 2 min, denaturation at 94°C for 30 s, annealing at 40°C for 2 min, and extension at 72°C for 30 s for 40 cycles followed by 72°C for 5 min. Labeled cDNA fragments were analyzed on a denaturing 6% polyacrylamide gel. Reproducibility was confirmed by repeating the assay as described above with RNA samples from cortex. Bands of interest were excised from the gel, reamplified without isotope, and used for cloning.
Cloning and sequence analysis
Amplified cDNA fragments were directly cloned into the TA-cloning vector pCR2.1 (Invitrogen). Plasmid DNA was sequenced on both strands by the dideoxynucleotide method (Sanger et al., 1977) , and the sequences were analyzed by searching EMBL and GenBank data bases with Genetics Computer Group software (Biotechnology Center, University of Wisconsin, Madison, WI, U.S.A.).
Northern blot analysis
Northern blots were prepared as described (Link et al., 1995) with 5-10 g of total RNA per lane. A 1,479-bp rat GPDH cDNA fragment from the 3Ј end of the GPDH mRNA was generated by PCR with primers 5Ј CGGGATCCAACTAAGC-CCCAGTGGTGCC 3Ј and 5Ј CTGATCATGGGTAGA-CAAGTGGCCTGA 3Ј (Ireland et al., 1986) . Specific probes were labeled with [␣- 32 P]dCTP (Random Primer Labeling Kit; GibcoBRL). Hybridization with a cDNA fragment of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Fort et al., 1985) was used as control for the loading of the gel. For quantitation, blots were analyzed on the Bas 1500 Bioimaging Analyzer using the TINA 2.0 software. The signals were normalized with the values obtained from the corresponding GAPDH band. Each experiment was repeated at least three times, and each sample was the pool of two animals.
In situ hybridization
In situ hybridization of brain (Link et al., 1995) and spinal cord (Naranjo et al., 1991b) sections was as described. Sections from control and experimental tissue were mounted on the same slide to allow identical hybridization conditions. Sense and antisense probes were labeled with uridine [␣-
35 S]thiotriphosphate. Slides were exposed to film (␤-Max; Amersham) and photographic emulsion (NTB2; Kodak) and counterstained with cresyl violet. Nonradioactive in situ hybridization of spinal cord samples with sense and antisense probes labeled with digoxygenin-UTP (Roche) was performed as described (Lucas et al., 1993) .
RESULTS
Differential display identifies induction of GPDH in hippocampus after seizure activity
Duplicate differential display patterns of hippocampal mRNAs isolated 5 h after PTZ-induced seizure, 4 h after PTZ-induced seizure in the presence of CHX, and from controls were compared to identify genes whose mRNA levels were increased by neuronal activity. PCR amplification with a single 10-mer primer GATGGCCTGG resulted in a 248-bp band that was present in all six lanes but was specifically increased 5 h after PTZ-induced seizure as compared with control or samples from mice that received CHX before PTZ administration (Fig. 1A) . Sequence analysis of the 248-bp fragment showed identity with a stretch of the 3Ј untranslated region of murine NAD ϩ -dependent GPDH cDNA. To confirm the differential display results and further characterize the inducibility of the GPDH gene following increased neuronal activity, we performed northern blot analysis of hippocampus and cerebral cortex, two areas directly involved in seizure activity, at different times after convulsions. Moreover, we analyzed the inducibility in rat spinal cord after noxious stimulation. A single mRNA species of 2.9 kb was detected in all samples, in keeping with previous reports (Masters et al., 1994) . In the hippocampus, the level of GPDH mRNA was increased at 1 h, peaked (fourfold) at 4 h, and decreased to basal values at 10 h following PTZ-induced seizure (Fig.  1B) . GPDH induction also occurred in the cerebral cortex after PTZ and followed a comparable time course (Fig. 1C) . Injection of KA induced seizures that developed more slowly and recurred for several hours. However, the induction of GPDH mRNA was similar, with a 4.5-fold increase in the hippocampus (Fig. 1B ) and 2.7-fold increase in the cerebral cortex (Fig. 1C) . These results indicate that a single PTZ injection is sufficient to maximally induce the GPDH gene. Interestingly, induction of GPDH mRNA was detectable in lumbar spinal cord 1 h following noxious stimulation of the hindpaws. The increase was 2.5-fold at 4 h, and GPDH mRNA levels remained significantly elevated 8 h after the pain stimulus (Fig. 1D) . Thus, induction of the GPDH gene occurs in brain and spinal cord following two independent models for neuronal activation. Furthermore, in agreement with the differential display results, administration of CHX before PTZ-induced seizure (Fig. 1B) or noxious stimulation (data not shown) blocked the induction of GPDH. These results indicate that GPDH is a late effector gene whose expression depends on de novo protein synthesis.
Activity-dependent GPDH induction occurs mostly in white matter
Induced levels of GPDH mRNA after cortisol-or stress-mediated elevation of adrenal corticoids have been observed to be widely distributed throughout the rat brain, predominantly in oligodendrocytes in the white matter (Leveille et al., 1980; Masters et al., 1994) . To gain insight into the spatial pattern of GPDH induction in rat brain following PTZ and in the spinal cord after noxious stimulation, the distribution of GPDH mRNA was investigated using in situ hybridization (Fig. 2) . Coronal and parasagittal brain sections were hybridized with antisense and sense 35 S-labeled cRNA probes for GPDH. In control sections, the hybridization signal was restricted mainly to the white matter of the brain ( Fig. 2A and C). One hour after PTZ-induced seizures, a slightly elevated hybridization signal could be detected (data not shown). Four hours after PTZ-induced seizures, a dramatic increase of GPDH transcripts was readily observed in areas rich in white matter, including fimbria, corpus callosum, olfactory, optic, and mammillothalamic tracts, anterior commissure, inner capsule, as well as hippocampus and globus pallidus ( Fig. 2B and D) . Importantly, no significant induction of GPDH mRNA could be detected in white matter of cerebellum at any time after seizure activity (Fig. 2B) . Emulsion photomicrographs counterstained with cresyl violet show, at higher magnification, the specific accumulation of GPDH transcripts in the soma of labeled cells ( Fig. 2G and H) . Control hybridizations using the sense cRNA probe (Fig. 2E ) did not result in any specific signal at any time after seizure activity or noxious stimulation. Moreover, in agreement with differential display and northern blot results, in situ showing the induction of GPDH in duplicate samples isolated from hippocampus 5 h after the onset of PTZ-induced synaptic activity. Induced levels do not occur in hippocampal samples from rats injected with PTZ together with CHX (C/P). Control animals (C) were injected with the same volume of saline. B and C: Time course of the induction of GPDH mRNA levels in the hippocampus (B) and in the cortex (C) after seizure activity induced by PTZ. Numbers below the lanes indicate time in hours after administration of PTZ at which RNA was isolated. For comparison, induced GPDH levels 4 h after KA are shown. Blockage of the GPDH induction in the hippocampus after PTZ by CHX is also shown (C/P). D: Time course of the GPDH induction in lumbar spinal cord following thermal noxious stimulation at 52°C. Control rats (C) were handled in the same way with thermal stimulation at 37°C. Numbers below the lanes indicate time in hours after thermal noxious stimulation. To control for the loading of the different lanes, blots were rehybridized with a probe specific for GAPDH. The positions of GPDH and GAPDH mRNA are indicated by arrows.
hybridization of brain sections from rats that received CHX prior to PTZ injection or noxious stimulation (Fig.  2F and data not shown) did not show the increased levels of GPDH. In situ hybridization in lumbar spinal sections revealed a strong induction of the GPDH signal after thermal noxious stimulation compared with the weak hybridization signal in control spinal cords. Interestingly, positive cells were abundant and scattered throughout the different laminae of the gray matter, with some located also in the white matter (Fig. 3) .
Permissive effect of adrenal glucocorticoids on activity-dependent GPDH induction
To investigate the role of circulating glucocorticoids on GPDH expression after neuronal activity, adrenalectomized rats were prepared. As previously described in brain (Masters et al., 1994) , adrenalectomy strongly reduced the basal level of GPDH expression in brain and spinal cord as compared with sham-operated animals. Moreover, no specific hybridization signals could be detected in the brains of adrenalectomized animals after PTZ injection (Fig. 4A) . Furthermore, northern blot analysis showed that GPDH induction in lumbar spinal cord after noxious stimulation was also blocked in adrenalectomized rats (Fig. 4B) . Replacement of glucocorticoids by DEX in these animals increased GPDH expression over basal level in sham-operated rats (Fig. 4B) . These data indicate that the increase of GPDH mRNA after neuronal activity is under control of adrenal steroids.
Morphine and NSAIDs induce GPDH gene expression
To ascertain the functional significance of GPDH mRNA induction in lumbar spinal cord after peripheral noxious stimulation, rats were given an analgesic dose of morphine before the thermal stimulation was applied. Unexpectedly, northern blot analysis of lumbar spinal cord revealed that morphine itself increased GPDH mRNA (Fig. 5A) . The effect of morphine on GPDH mRNA levels was dose dependent, with no effect at 1   FIG. 2 . In situ hybridization of GPDH in rat brain: expression of GPDH mRNA in control brain and after PTZ-induced seizures. Parasagittal (A and B) and coronal (C-F) sections were hybridized with sense (E) and antisense (A-D, F-H) probes. Autoradiographs (A-F) and emulsion photomicrographs (G and H) are shown. Control animals (A and C) and animals killed 4 h after the onset of seizures (B, D, E, G, and H) and 4 h after seizure in the presence of CHX (F) were analyzed. Notice that strong hybridization was confined mainly to fiber tracts. Higher magnification of the hippocampus (G) and the corpus callosum (H) is shown. cc, corpus callosum; fi, fimbria hippocampus; lhb, lateral habenula; olt, olfactory tract; opt, optic tract; mt, mamillothalamic tract; ac, anterior commissure. Bars ϭ 1 mm (A-F), 250 m (G), and 12 m (H).
mg/kg, a slight but significant increase at 5 mg/kg, and a twofold induction with 10 mg/kg. We next examined whether GPDH induction is a general phenomenon associated with drug-induced analgesia or if it is specific for morphine. To do so, a set of nonnarcotic NSAIDs widely used for pain treatment in humans were injected intraperitoneally in rats. Treatment with metamizol (dipyrone), aspirin, and indomethacin resulted in a dosedependent induction of GPDH in rat lumbar spinal cord (Fig. 5B-D) . Metamizol slightly induced GPDH mRNA levels at 50 mg/kg, and further increases were observed after injection of 125 and 250 mg/kg (Fig. 5B) . A similar dose-response effect was obtained with aspirin ( Fig.  5C ), whereas GPDH induction was detectable after administration of 1 mg/kg indomethacin and further increased with 2.5 and 4.5 mg/kg (Fig. 5D) . Kinetic analysis of the induction of GPDH was performed after metamizol. Induction of GPDH in lumbar spinal cord was noticeable at 2 h, showed a peak of accumulation at 4 h, and was still significantly elevated 8 h after treatment (Fig. 5E) . Moreover, in situ hybridization showed that the induction of GPDH mRNA 4 h after metamizol is widely distributed throughout the different laminae of the spinal cord ( Fig. 5F and G and data not shown). Thus, the time course and the distribution of GPDH induction after metamizol were similar to those observed following noxious thermal stimulation. Importantly, the induction of GPDH mRNA after morphine was completely blocked by pretreatment with 1 mg/kg naloxone, indicating that morphine specifically interacts with opioid receptors to increase GPDH gene expression (Fig. 6A) . On the other hand, naloxone treatment did not block heat-or NSAID-induced GPDH up-regulation, suggesting that endogenous opioid peptides do not mediate the increase in GPDH expression after noxious stimulation or NSAIDs (Fig. 6A) .
To test for a possible additive effect between morphine and NSAIDs on GPDH expression, subeffective doses of morphine (1 mg/kg) and metamizol (125 mg/kg) were coadministered. The increase in GPDH transcripts after the combined administration of morphine and metamizol was not significantly higher than after 125 mg/kg metamizol alone (data not shown).
Glucocorticoids and new protein synthesis are required for GPDH induction after administration of analgesics
To investigate the effect of glucocorticoids on GPDH expression after morphine and NSAID treatment, adrenalectomized animals were prepared. Four hours after morphine, metamizol, aspirin, and indomethacin treatment, the increase in GPDH transcripts was completely abolished in adrenalectomized animals (Fig. 6B ). These data indicate that the increase in GPDH mRNA following morphine and NSAIDs is under control of adrenal steroids.
FIG. 4. Activity-dependent induction of GPDH requires adrenal glucocorticoids. A:
In situ hybridization of the brain sections from an adrenalectomized (ADX) rat 4 h after PTZ. Compare with nonadrenalectomized rat 4 h after PTZ shown in Fig. 2D . B: Northern blot analysis of GPDH mRNA levels in the spinal cord 4 h after different treatments. Sham-operated animal controls (C/Sh) and after noxious stimulation (52°C/Sh) as well as adrenalectomized animal (ADX) controls (C) and animals after noxious stimulation (52°C) and after DEX injection were analyzed.
FIG. 3.
In situ hybridization for GPDH in rat lumbar spinal cord. Transverse sections were hybridized with a digoxygenin-labeled cRNA probe. Control (37°C) and heat-stimulated (52°C) rats were killed 4 h after stimulation. Induction of GPDH mRNA occurs in all laminae of the spinal cord in both white and gray matter. Bar ϭ 150 m.
GPDH INDUCTION BY NEURAL ACTIVITY AND ANALGESICS
To investigate the role of protein synthesis in GPDH mRNA induction by analgesic drugs, experiments were performed with the protein synthesis inhibitor CHX. In keeping with previous results of the induction of GPDH mRNA by glucocorticoids (de Vellis and Inglish, 1968; Masters et al., 1994) or by neuronal activation (described above), the induction by metamizol and aspirin was completely prevented by CHX (Fig. 6C) . These results suggest that the synthesis of one or more intermediate proteins is a rate-limiting step in the regulation of GPDH mRNA levels.
DISCUSSION
We used mRNA differential display to identify genes whose expression is regulated during synaptic activity. We found that GPDH mRNA is induced after PTZ and KA injection in rat brain and following noxious stimulation in the lumbar spinal cord. Surprisingly, administration of analgesic drugs did not block pain-induced increase in GPDH mRNA accumulation but instead induced the same effect. Presently, we cannot discriminate whether the observed induction of GPDH mRNA is due to transcriptional activation or modulation of mRNA stability. Both mechanisms have been reported to operate in the regulation of GPDH in cultured adipocytes (Bhandari et al., 1991) .
Permissive effect of glucocorticoids on GPDH induction
The induction of GPDH mRNA after seizure, pain stimulation, or administration of analgesic drugs required normal levels of circulating glucocorticoids, as in all cases the induction was completely blocked in adrenalectomized animals. In fact, decreased GPDH mRNA levels in spinal cord of adrenalectomized rats were restored by administration of DEX. These results confirm and extend previous reports of the permissive effect of glucocorticoids on the expression of GPDH in the adult rat brain (Orti et al., 1987; Masters et al., 1994; Kitraki et al., 1995) . Glucocorticoids interact with cytoplasmic receptors and induce their translocation to the nucleus. The steroid-receptor complex binds to specific DNA sequences, glucocorticoid-responsive elements (GREs), and functions as a sequence-specific transcription factor. Early work by Ireland et al. (1986) highlighted two putative GREs in the GPDH promoter, but more recent detailed promoter analysis by the same group did not confirm the presence of functional GREs in the GPDH promoter (Gwynn et al., 1990; Birkenmeier et al., 1992) . Alternatively, glucocorticoids are able to modify transcription through indirect mechanisms that require ongoing protein synthesis (Davis et al., 1987) . The fact that the increase in GPDH mRNA level can be blocked by CHX suggests the involvement of de novo synthesized proteins in the regulation of GPDH gene expression and raises the question of whether the hormone-receptor complex interacts directly with the GPDH promoter. One possible explanation for the blockage of GPDH induction in the absence of protein synthesis is that CHX might limit the availability of a putative cofactor that interacts with the steroid-receptor complex to regulate GPDH expression. Such a mechanism was proposed to operate in the CHX-dependent regulation of the -class glutathione S-transferase gene by corticoids (Fan et al., 1992) . Recently, several coactivators and corepressors of the transcriptional activity of hormone receptor complexes have been identified, including the CREB binding protein (CBP) (Kamei et al., 1996; Voegel et al., 1996) . A second possibility is that glucocorticoids do not act directly upon the GPDH gene, but the effect is mediated by glucocorticoid-inducible factors that in turn induce the transcription of GPDH or stabilize GPDH transcripts. This mechanism has been proposed for the regulation of the ␣ 2 -globulin gene by glucocorticoids (Addison and Kurtz, 1986) , though the nuclear proteins involved in the process are still unknown. Further studies using footprinting and southwestern analysis could help to identify nuclear mediators of GPDH expression.
The induction of GPDH mRNA levels occurred with similar kinetics in hippocampus, cortex, and spinal cord with a peak at 4 h after stimulation. However, the levels of GPDH transcripts in spinal cord after noxious stimulation or analgesic treatment remained elevated for longer periods, whereas in the hippocampus and cortex, the effect was more transient. The molecular basis of this tissue-specific time course is presently unknown, though differences in the availability of glucocorticoid receptors in the hippocampus versus the spinal cord have been reported (de Kloet et al., 1993 ). An in situ hybridization study showed that GPDH mRNA is increased in whitematter fiber tracts all over the brain after corticosterone administration or exposure of the animal to different types of stress (Masters et al., 1994) . In our study, the pattern of GPDH induction in brain after neuronal stimulation is similar, except that in our model we do not observe any significant increase in GPDH mRNA levels in the white matter of the cerebellum. This difference points out the specificity of the GPDH induction after neuronal activation and indicates that the effect is not due exclusively to the stress associated with seizure activity. Nevertheless, it has been demonstrated that the release of adrenal glucocorticoids induced by seizure activity can mediate or modulate the effects of neuronal activity on gene expression. For instance, it has been shown that immediate early gene induction is potentiated in adrenalectomized rats (Li et al., 1992) , whereas adrenalectomy blocks KA-induced increase of nerve growth factor mRNA and reduces the induction of brain-derived neurotrophic factor and trkB in hippocampus (Barbany and Persson, 1993) . The functional meaning of the permissive effect of glucocorticoids on GPDH inducibility in adult nervous system remains unknown. GPDH might participate in different neuroprotective processes as an adaptive/repair response to components of stress after seizure and in the endogenous mechanisms of pain control.
Relation of induction of GPDH to endogenous mechanisms of pain control
The molecular mechanism underlying the opiate signal transduction cascade that leads to GPDH accumulation is presently not understood. The specific blockage by naloxone, however, demonstrates that morphine-induced GPDH increase is mediated by opioid receptors. Activation of the receptor, which is preferred by morphine, provokes the attenuation of neurotransmitter release from various neuronal cells (Pang and Vasko, 1986 ) and the inhibition of adenylate cyclase activity (Sharma et al., 1975) . A permissive effect of glucocorticoids on cyclic AMP-dependent transcription has been reported for several genes (Ruiz-Bravo and Ernest, 1982; Lewis et al., 1983; Naranjo et al., 1986) including GPDH (Breen et al., 1978) . Furthermore, it has been shown that cyclic AMP stabilizes GPDH transcripts in 3T3-L1 adipocytes (Bhandari et al., 1991) . Thus, the effect of morphine must involve a different mechanism. On the other hand, activation of the hypothalamic-pituitary-adrenal axis is thought to be an important component of the neuroendocrine response to opiates. Elevated corticotropin-releasing factor has been implicated in anxiety and stress during withdrawal from drugs of abuse such as opioids, cocaine, and cannabinoid (Rodriguez de Fonseca et al., 1997) , and other studies show that plasma corticosterone level increases significantly after acute morphine administration (Adamson et al., 1991) . This suggests that the effect of morphine on the expression of GPDH is not cell autonomous; further studies utilizing double-labeling techniques are necessary to colocalize the expression of opioid receptors and the induced levels of GPDH.
The lack of effect of naloxone on GPDH induction following thermal noxious stimulation or metamizol administration indicates that pain and nonopioid analgesics utilize an opioid-receptor-independent mechanism. The NSAIDs used in this study are inhibitors of cyclooxygenases (Vane and Botting, 1987; Shimada et al., 1994) , which are rate-limiting enzymes in prostaglandin and thromboxane synthesis. In particular, it has been proposed that the central effects of NSAIDs are due to blockade of prostaglandins (Cherng et al., 1996) and their effects on gene expression (Cowlen and Eling, 1992; Danesch et al., 1994) . Nevertheless, other mechanisms have been considered. First, aspirin directly affects gene expression inhibiting the activation of the transcription factor nuclear factor-B (Kopp and Gosh, 1994) . This mechanism mediates the blockage of lipopolysaccharide-induced inducible NO synthase expression in murine macrophages (Amin et al., 1995) . Interestingly, the induction of inducible NO synthase is also blocked by hydrocortisone. Second, NSAIDs can interfere with G-protein-mediated signal transduction mechanisms not directly related to inhibition of prostaglandin synthesis (Cashman, 1996) . Third, NSAIDs might activate an endogenous analgesic substance (Walker, 1995) . This mechanism has been hypothesized based on the delay in the peak of analgesic activity with respect to the peak in plasma concentration observed for opioids and nonopioid analgesics (Berkowitz et al., 1969; Laska et al., 1986) . The facts that pain, as well as administration of analgesics, up-regulate GPDH expression suggest the implication of GPDH in the endogenous mechanisms of pain control. Nevertheless, the lack of a synergistic effect on GPDH induction between subanalgesic doses of morphine and metamizol, previously reported to occur in tests of analgesia as well as in the reduction of c-fos inducibility (Taylor et al., 1998) , adds further complexity to the understanding of the functional meaning of GPDH induction in the CNS.
CONCLUSION
In conclusion, we propose that glucocorticoids regulate basal and inducible expression of GPDH through a mechanism that involves a second nuclear factor that is rate limiting and whose amount or activity is directly regulated by neuronal activity and analgesics. Further experiments are required to identify this nuclear activity and to understand the molecular mechanisms that control GPDH gene expression.
